Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 21.19
+1.56 (7.95%)
May 8, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 12.61 billion as of May 8, 2026. Its market cap has increased by 34.97% in one year.
Market Cap
12.61B
Enterprise Value
10.04B
Revenue
1.20B
Ranking
n/a
PE Ratio
67.25
Stock Price
21.19
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 12.61B, a decrease of -55.16%. That is a compound annual growth rate of -17.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 12.61B | 13.74% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 13.69B |
| Inner Mongolia Furui Medical Science | 13.62B |
| Tibet Cheezheng Tibetan Medicine | 13.08B |
| InventisBio | 12.72B |
| HitGen | 11.60B |
| Vcanbio Cell & Gene Engineering Corp., | 11.39B |
| Pacific Shuanglin Bio-pharmacy | 11.10B |
| Chongqing Genrix Biopharmaceutical | 11.05B |